- Home
- EVC vs CDTX Comparison
EVC vs CDTX Comparison
Compare EVC & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- CDTX
- Stock Information
- Founded
- EVC 1996
- CDTX 2012
- Country
- EVC United States
- CDTX United States
- Employees
- EVC N/A
- CDTX N/A
- Industry
- EVC Broadcasting
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVC Industrials
- CDTX Health Care
- Exchange
- EVC Nasdaq
- CDTX Nasdaq
- Market Cap
- EVC 229.5M
- CDTX 242.5M
- IPO Year
- EVC 2000
- CDTX 2015
- Fundamental
- Price
- EVC $2.69
- CDTX $20.21
- Analyst Decision
- EVC Hold
- CDTX Strong Buy
- Analyst Count
- EVC 1
- CDTX 6
- Target Price
- EVC $1.75
- CDTX $32.20
- AVG Volume (30 Days)
- EVC 349.2K
- CDTX 84.3K
- Earning Date
- EVC 11-06-2024
- CDTX 11-07-2024
- Dividend Yield
- EVC 8.37%
- CDTX N/A
- EPS Growth
- EVC N/A
- CDTX N/A
- EPS
- EVC N/A
- CDTX N/A
- Revenue
- EVC $1,146,066,000.00
- CDTX $44,653,000.00
- Revenue This Year
- EVC N/A
- CDTX N/A
- Revenue Next Year
- EVC N/A
- CDTX N/A
- P/E Ratio
- EVC N/A
- CDTX N/A
- Revenue Growth
- EVC 122.49
- CDTX 44.48
- 52 Week Low
- EVC $1.33
- CDTX $10.00
- 52 Week High
- EVC $4.41
- CDTX $24.99
- Technical
- Relative Strength Index (RSI)
- EVC 49.08
- CDTX 66.36
- Support Level
- EVC $2.36
- CDTX $22.10
- Resistance Level
- EVC $2.50
- CDTX $24.99
- Average True Range (ATR)
- EVC 0.10
- CDTX 1.88
- MACD
- EVC -0.01
- CDTX -0.00
- Stochastic Oscillator
- EVC 20.00
- CDTX 70.84
About EVC Entravision Communications Corporation
Entravision Communications Corp is a global advertising solutions, media, and technology company. Its operations encompass integrated marketing and media solutions, comprised of television, radio, and digital properties and data analytics services. The company operates in television broadcasting, audio broadcasting, and digital media segments. The Company's digital segment, whose operations are located in Europe, Latin America, Asia, the United States, and Africa. The Company's television and audio operations reach and engage U.S. Hispanics in the United States.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.